vigabatrin has been researched along with Encephalopathy, Hepatic in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Based on the reversal of hepatic encephalopathy in animal models with administration of specific benzodiazepine receptor antagonists, it has been postulated that this syndrome may be mediated by an endogenous benzodiazepine-like compound." | 1.28 | Evidence for the presence of a benzodiazepine receptor binding substance in cerebrospinal fluid of a rabbit model of hepatic encephalopathy. ( Jones, EA; Kaminsky-Russ, K; Martin, JV; Mendelson, WB; Mullen, KD, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mullen, KD | 1 |
| Martin, JV | 1 |
| Mendelson, WB | 1 |
| Kaminsky-Russ, K | 1 |
| Jones, EA | 1 |
1 other study available for vigabatrin and Encephalopathy, Hepatic
| Article | Year |
|---|---|
Evidence for the presence of a benzodiazepine receptor binding substance in cerebrospinal fluid of a rabbit model of hepatic encephalopathy.
Topics: Aminocaproates; Animals; Binding, Competitive; Flumazenil; GABA-A Receptor Antagonists; Galactosamin | 1989 |